Table 2.

Five-year mortality (%)^* and relative risk of mortality (HR)^** according to MELD score at first potential living donor evaluation for transplant candidates without HCC

MELD at Entry	LDLT 5-yr mortality (%)	Non-LDLT 5-yr mortality (%)	HR LDLT v. No LDLT	95% CI	p-value
MELD 6–10	5.5%	32.1%	0.43	(0.17, 1.05)	0.063
MELD 11–14	24.0%	36.0%	0.38	(0.21, 0.70)	0.0021
MELD 15–19	14.3%	27.6%	0.42	(0.23, 0.77)	0.005
MELD 20+	20.1%	33.4%	0.44	(0.19, 1.02)	0.056

^*Mortality shown for patient age=50, with HCV, no other cholestatic disease, and MELD=8, 12, 16, and 25 for the MELD<10, 11–14, 15–19, and 20+ groups respectively.

^**Based on sequential stratification model (see text)